Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-23

Clinical Trial Update: Immunization of Human Volunteers With P. Vivax Irradiated Sporozoites [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial update of immunizing volunteers with Plasmodium vivax irradiated sporozoites for malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • P. vivax irradiated sporozoites vaccine (P. vivax irradiated sporozoites)

Snippet

Sponsor: Malaria Vaccine and Drug Development Center | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED